Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Docetaxel Toxicity”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Not applicableUnknownNCT01891123
What this trial is testing

Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy

Who this might be right for
Non-small Cell Lung CancerBreast CancerNasal Cancer
Sun Yat-sen University 300
Testing effectiveness (Phase 2)Ended earlyNCT00551759
What this trial is testing

Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Eastern Cooperative Oncology Group 22
Testing effectiveness (Phase 2)WithdrawnNCT03343977
What this trial is testing

Toxicity & Pharmacokinetics of 2 & 3-weekly Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer
Peng Wang, MD PhD
Testing effectiveness (Phase 2)Study completedNCT01596868
What this trial is testing

GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest China

Who this might be right for
Nasopharyngeal Squamous Cell CarcinomaToxicity Due to Radiotherapy
Air Force Military Medical University, China 60
Not applicableStudy completedNCT01053104
What this trial is testing

Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring

Who this might be right for
Metastatic Colorectal CancerMetastatic Breast Cancer
University of Oxford 26
Large-scale testing (Phase 3)Study completedNCT02973789
What this trial is testing

Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)

Who this might be right for
Nonsmall Cell Lung CancerNSCLC
NovoCure GmbH 291
Testing effectiveness (Phase 2)Study completedNCT00721513
What this trial is testing

Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Wake Forest University Health Sciences 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06360978
What this trial is testing

Efficacy and Toxicity of Docetaxel as a Radiosenstizer in Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Assiut University 30
Early research (Phase 1)WithdrawnNCT01562301
What this trial is testing

Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Chemotherapeutic Agent ToxicityLung Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT04999332
What this trial is testing

Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancer

Who this might be right for
Gastric CancerGastric AdenocarcinomaEffects of Chemotherapy+1 more
National Cheng-Kung University Hospital 58
Testing effectiveness (Phase 2)Ended earlyNCT01558011
What this trial is testing

Using Genetic Polymorphisms to Predict the Efficacy and Toxicity - A Gastric Adenocarcinoma Study

Who this might be right for
Gastric Adenocarcinoma
National Health Research Institutes, Taiwan 51
Testing effectiveness (Phase 2)WithdrawnNCT01750866
What this trial is testing

Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer

Who this might be right for
Castrate-resistant Metastatic Prostate Cancer
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00077311
What this trial is testing

Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
AnemiaDrug/Agent Toxicity by Tissue/OrganLung Cancer+1 more
Alliance for Clinical Trials in Oncology 160
Large-scale testing (Phase 3)Study completedNCT00911352
What this trial is testing

Cryotherapy Intervention for Docetaxel-induced Nail Toxicities

Who this might be right for
Effects of Chemotherapy
Princess Alexandra Hospital, Brisbane, Australia 65
Testing effectiveness (Phase 2)UnknownNCT01192230
What this trial is testing

Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Fudan University 30
Testing effectiveness (Phase 2)Study completedNCT00695994
What this trial is testing

The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian Patients

Who this might be right for
Non Small Cell Lung CancerBreast Cancer
National University Hospital, Singapore 300
Testing effectiveness (Phase 2)Study completedNCT00942578
What this trial is testing

Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
National Cancer Institute (NCI) 63
Large-scale testing (Phase 3)Study completedNCT00925418
What this trial is testing

Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate Cancer

Who this might be right for
Breast NeoplasmsProstate CancerNail Diseases
Institut Paoli-Calmettes 168
Not applicableStudy completedNCT02283983
What this trial is testing

Evaluation of Cryoprotection Induced Nail Toxicity Docetaxel Low Cumulative Dose

Who this might be right for
Breast Neoplasms
Centre Hospitalier Departemental Vendee 319
Not applicableStudy completedNCT01110291
What this trial is testing

Study of Usefulness of Genotyping to Predict Docetaxel Exposure and Adverse Events

Who this might be right for
CYP3A PhenotypingCYP3A5 and MDR1 GenotypingDocetaxel Toxicity+1 more
University of Turku 20
Next Page